Menu
Recruiting NCT07128966

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

Observational Healthy Lupus Celiac Kidney Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Observation.
Who it may be relevant to
Registry conditions: Healthy, Lupus, Celiac, Kidney Disease. Basic parameters: 18 years — 90 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Joined Bio - JB-MR-250225, Direct to Patient Minimal Risk Research

Overview

This study aims to help researchers better understand health conditions and develop improved tests, treatments, and cures for diseases. Joined Bio collects health data, lifestyle information, biological samples, and feedback from participants and provides this to qualified research partners.

Detailed description

Primary: The primary objective of this study is to connect participants with specific health profiles, along with biospecimens and associated de-identified health data, to scientific researchers who are searching for new diagnostics and treatments for a wide array of conditions. This will accelerate medical discovery by connecting medical research with the power of patient participation.

Secondary: The secondary objective of this study is to allow participants with specific health profiles, along with their de-identified health data, to help further the cause of medicine generally through interviews, surveys, and other minimal risk research activities desired by life science organizations.

Interventions

  • Other Observation
    This is non-interventional, observational only

Primary outcome measures

  • Observation for biomarker identification [Time frame: 10 years]

Eligibility criteria

Inclusion criteria

  • Male or female, that are adults \[have reached the Age of Majority = aged 18 to 90 in most US states; aged 19-90 in Alabama or Nebraska; aged 21-90 in Mississippi or Puerto Rico\].
  • Have reviewed and signed a consent or e-consent form for this study. If a person with diminished decision-making capacity, their Legally Authorized Representative has reviewed and signed the consent for on their behalf.
  • Be willing to comply with all study procedures and be available for the duration of the study.
  • Meets requirements of a current request for research participation (e.g. has previous diagnosis of a medical condition of interest or laboratory results within a specific range).
  • Pregnant women may be enrolled in this study in accordance with 45 CFR Part 46 Subpart B.

Exclusion criteria

  • Unable to meet the Inclusion Criteria listed above.
  • Prisoners or children
  • Unable to provide the requested biospecimen(s), data or feedback without placing the individual at risk.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

United States · 1 center
  • Joined Bio — Lexington

Identifiers

NCT: NCT07128966 · JB-MR-250225 · JB Direct to Participant

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗